Skip to main content

Your search for “NIH Director” returned 211 results

Scientists Expand CRISPR-Cas9 Genetic Inheritance Control in Mammals

January 11, 2022

UC San Diego biologists have developed a method for genetic inheritance control in male mice, an achievement that advances new laboratory models in an array of research pursuits, from investigations of human disease to therapeutic drug design to invasive species removal.

Researchers Continue Study of COVID-19 Vaccinations, Pregnancy and Postpartum

June 23, 2022

A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.

IDASH Projects: Protecting Privacy and Patient Rights in the Name of Scientific Progress

September 10, 2013

In the years since the best-selling book “The Immortal Life of Henrietta Lacks” made the issue of informed consent and patient privacy a national topic of conversation, scientists and clinicians have continued to struggle to develop a comprehensive methodology for collecting and sharing data from patients and research subjects without…

Study Identifies Cause for Excessive Folding of Gyri in Human Cerebral Cortex

January 18, 2023

UC San Diego researchers identify mutation that causes excessive folding in human brain’s wrinkly cerebral cortex, resulting in diminished cognitive function.

NIH Funds New Program to Broaden Diversity in Neurobiology

April 8, 2021

…San Diego neurobiology students. NIH Funds New Program to Broaden Diversity in Neurobiology STARTneuro designed to support and mentor transfer students from underrepresented backgrounds For some students, stepping onto the sprawling UC San Diego campus for the first time can be daunting. For transfer students, the challenges can escalate, given…

Phase I Trial Finds Experimental Drug Safe in Treating Chronic Lymphocytic Leukemia

June 1, 2018

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the “stemness” of chronic lymphocytic leukemia cancer (CLL) cells — their ability to self-renew and resist terminal differentiation…

Zafiris J. Daskalakis, MD, PhD, Named Chair of the Department of Psychiatry

July 30, 2020

Zafiris J. “Jeff” Daskalakis, MD, PhD, has been named chair of the Department of Psychiatry at University of California San Diego School of Medicine.

Pivotal Inflammatory Players Revealed in Diabetic Kidney Disease

April 8, 2016

In a new study, published in the online edition of the journal EBioMedicine, a multi-disciplinary team led by researchers at University of California, San Diego School of Medicine has identified key inflammatory mechanisms underlying type 1 diabetes and obesity-related kidney dysfunction.

Diabetes in a Dish

October 1, 2014

Researchers at University of California, San Diego School of Medicine are co-recipients of a $4.1-million grant from the National Institutes of Health to advance treatments for type 1 diabetes. Using human stem cells, the team plans to culture bits of human pancreas in a dish and, using microfluidics, mimic blood…

Small Molecule Drug Reverses ADAR1-induced Cancer Stem Cell Cloning Capacity

February 16, 2023

UC San Diego researchers report that a late-stage, pre-clinical small molecule inhibitor reverses malignant hyper-editing by a protein that promotes silencing of the immune response, metastasis and therapeutic resistance in 20 different cancer types.

Category navigation with Social links